Dermatology & Immunology
Atopic Dermatitis Clinical Research
Atopic dermatitis (eczema) is a chronic inflammatory skin condition that affects millions of children, adolescents, and adults worldwide. CenExel partners with sponsors to advance innovative dermatology treatments through specialized clinical research, diverse patient recruitment, and experienced investigative teams.
Studies Conducted
0
+
Trial Participants
0
+
Active Centers
0
Overview
Advancing Atopic Dermatitis Research Through Specialized Clinical Trials
CenExel provides comprehensive support for atopic dermatitis and inflammatory skin disease studies, combining scientific expertise, operational excellence, and participant-focused care. Our experienced dermatology research teams help accelerate clinical development from early-phase studies through late-stage trials.
Conditions Covered
Dermatology Conditions We Research
Our dermatology research sites support a broad range of inflammatory and immune-mediated skin disorders.
- Atopic Dermatitis (Eczema)
- Chronic Pruritus
- Contact Dermatitis
- Pediatric Eczema
- Psoriasis
- Seborrheic Dermatitis
- Hand Eczema
- Prurigo Nodularis
Our Approach
Why Sponsors Choose CenExel for Dermatology Research
CenExel’s dermatology research expertise helps sponsors improve enrollment, operational efficiency, and participant engagement across clinical trials.
01
Experienced Dermatology Investigators
Our physician network includes experienced dermatology specialists with expertise in inflammatory skin disorders.
02
Strong Patient Recruitment
We use targeted outreach and digital recruitment strategies to support rapid enrollment.
03
Diverse Participant Populations
Access to broad demographic populations helps ensure inclusive dermatology research participation.
04
High Quality Trial Execution
Our operational teams focus on compliance, retention, and efficient study management.
Phase Coverage
Supported Dermatology Trial Phases
CenExel supports early and late-phase dermatology clinical research — from first-in-human studies through Phase IV post-market trials.
Active across all phases
- Phase I
- Phase II
- Phase III
- Phase IV
Our dermatology sites support biologics, topical therapies, immunology treatments, and innovative eczema therapies through experienced clinical operations and participant-centric care.
Let’s Advance Your Next Study
Looking for an experienced clinical research partner with the expertise, capabilities, and reach to move your study forward? Connect with CenExel to discuss your needs and explore how our network can support your clinical development goals.
Explore Our Network
Discover CenExel’s Centers of Excellence and find the locations, therapeutic expertise, and capabilities that align with your clinical development needs.
